Efficacy of fidaxomicin versus vancomycin in the treatment of Clostridium difficile infection: A systematic meta-analysis.|https://dx.doi.org/10.1097/MD.0000000000039213
The impact of 30-day antecedent antibiotic exposure on C. difficile ribotype patterns and the relationship with clinical outcomes: A single center study.|https://dx.doi.org/10.1016/j.anaerobe.2024.102894
Comparative effectiveness of vancomycin and metronidazole on event-free survival after initial infection in patients with Clostridioides difficile - a German multicentre cohort study (IBIS).|https://dx.doi.org/10.1016/j.cmi.2024.08.003
Symbiotic biofilms formed by Clostridioides difficile and bacteroides thetaiotaomicron in the presence of vancomycin.|https://dx.doi.org/10.1080/19490976.2024.2390133
Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?|https://dx.doi.org/10.1093/ageing/afae182
Microbiome modification for personalized treatment of dysbiotic diseases.|https://dx.doi.org/10.1016/j.chom.2024.07.023
Use of frozen native feces for fecal microbiota transplantation in recurrent Clostridioides difficile infection: a simple way to improve the efficiency of donor feces preparation.|https://dx.doi.org/10.1128/aac.00734-24
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTAÂ®) for Preventing Recurrent Clostridioides difficile Infection.|https://dx.doi.org/10.1093/infdis/jiae418
Reduction of Antibiotic-Associated Conditions After Tympanostomy Tube Placement in Children.|https://dx.doi.org/10.1002/lary.31717
